Fletcher/CSI Blog Biotech M&A: A Landscape of Strategic Shifts and Opportunities

Despite the known challenges and limitations inherent to biotech, this surge has propelled the industry onto a positive growth trajectory. Each transaction, big or small, holds the capacity to reshape the healthcare landscape, prompting frequent reviews and updates to strategic outlooks. READ MOREThe post Biotech M&A: A Landscape of Strategic Shifts and Opportunities appeared first on Fletcher - Global Competitive Insights.